The Albumin Excipient Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Albumin Excipient Market:
https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report
According to The Business Research Company’s Albumin Excipient Global Market Report 2024, The albumin excipient market size has grown strongly in recent years. It will grow from $4.56 billion in 2023 to $4.91 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to biopharmaceutical industry growth, increased adoption of biologics, risen prevalence of chronic diseases, clinical advancements and drug innovation, increased focus on drug delivery.
The albumin excipient market size is expected to see strong growth in the next few years. It will grow to $6.32 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to continued biopharmaceutical expansion, growing biologics pipeline, rising geriatric population, global vaccination initiatives, increasing drug development investments. Major trends in the forecast period include biodegradable and biocompatible properties, collaborations and partnerships in research, regulatory compliance and quality standards, application in cell therapy, customization and tailored solutions.
The rising prevalence of chronic diseases is expected to propel the growth of the albumin excipient market going forward. A chronic disease is a form of illness that lasts three months or more and can deteriorate with time. Albumin is used as a blood volumizer and is the most abundant circulating protein in plasma that acts as a versatile protein carrier for drug targeting and for improving the pharmacokinetic profile of peptide or protein-based drugs is involved in the treatment of various diseases, including cancer, and diabetes. For instance, in January 2023, according to The National Center for Biotechnology Information, the US-based National Library of Medicine, which the federal government operates, the number of people in the USA aged 50 and older who have at least one chronic condition would increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the rising prevalence of chronic diseases is driving the growth of the albumin excipient market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10672&type=smp
The albumin excipient market covered in this report is segmented –
1) By Product: Human Serum Albumin, Recombinant Albumin
2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users
Product innovations are a key trend gaining popularity in the albumin excipient market. Major companies operating in the albumin excipient market are introducing innovative solutions to sustain their position in the market. For instance, in November 2021, Grifols, S.A., a Spain-based healthcare company, introduced ALBUTEIN FlexBag (Albumin [Human] U.S.P.) in 5% and 25% concentrations, providing healthcare professionals with a more convenient option. The 5% concentration received U.S. Food and Drug Administration (FDA) approval in July 2021, featuring 250 mL and 500 mL bags, while the 25% concentration, approved earlier in the year, offers 50 mL and 100 mL bags. The ALBUTEIN FlexBag is available in various sizes and presented in an eco-friendly bag without plasticizers, offering a sustainable choice for healthcare professionals.
The albumin excipient market report table of contents includes:
1. Executive Summary
2. Albumin Excipient Market Characteristics
3. Albumin Excipient Market Trends And Strategies
4. Albumin Excipient Market Analysis
5. Albumin Excipient Market Size And Growth
6. Albumin Excipient Segmentation
7. Regional And Country Analysis
.
.
.
27. Albumin Excipient Competitive Landscape And Company Profiles
28. Albumin Excipient Key Mergers And Acquisitions
29. Albumin Excipient Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Albumin Therapeutics LLC
- Biotest AG
- CSL Behring
- Grifols S.A.
- HiMedia Laboratories LLC
- InVitria Inc.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively.
Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.China is the largest consumption place, with a consumption market share nearly 53.9% in 2017.
Following China, North America is the second largest consumption place with the consumption market share of 20% in 2017.Market competition is intense.
CSL, Grifols, Shire (Baxalta), Octapharma, Hualan Bio are the leaders of the industry, and have been formed in the monopoly position in the industry.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-albumin-2019-2024-962According to this study, over the next five years the Albumin market will register a 6.7% CAGR in terms of revenue, the global market size will reach US$ 6070 million by 2024, from US$ 4380 million in 2019.
In particular, this report presents the global market share (sales and revenue) of key companies in Albumin business, shared in Chapter 3.This report presents a comprehensive overview, market shares, and growth opportunities of Albumin market by product type, application, key manufacturers and key regions and countries.This study considers the Albumin value and volume generated from the sales of the following segments:Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.Human Serum AlbuminBovine Serum AlbuminRecombinant AlbuminSegmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.TherapeuticsVaccine IngredientCulture Medium IngredientOtherThis report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.AmericasUnited StatesCanadaMexicoBrazilAPACChinaJapanKoreaSoutheast AsiaIndiaAustraliaEuropeGermanyFranceUKItalyRussiaSpainMiddle East & AfricaEgyptSouth AfricaIsraelTurkeyGCC CountriesThe report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.The key manufacturers covered in this report: Breakdown data in in Chapter 3.CSLGrifolsShire (Baxalta)OctapharmaHualan BioCBPORAASKedrionMerckLFB GroupAlbumedixThermo Fisher ScientificVentria (InVitria)In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole.
It also analyzes key emerging trends and their impact on present and future development.Research objectivesTo study and analyze the global Albumin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.To understand the structure of Albumin market by identifying its various subsegments.Focuses on the key global Albumin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Albumin with respect to individual growth trends, future prospects, and their contribution to the total market.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).To project the consumption of Albumin submarkets, with respect to key regions (along with their respective key countries).To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.To strategically profile the key players and comprehensively analyze their growth strategies.Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-albumin-2019-2024-962Table of content2019–2024 Global Albumin Consumption Market Report1 Scope of the Report1.1 Market Introduction1.2 Research Objectives1.3 Years Considered1.4 Market Research Methodology1.5 Economic Indicators1.6 Currency Considered2 Executive Summary2.1 World Market Overview2.1.1 Global Albumin Consumption 2014–20242.1.2 Albumin Consumption CAGR by Region2.2 Albumin Segment by Type2.2.1 Human Serum Albumin2.2.2 Bovine Serum Albumin2.2.3 Recombinant Albumin2.3 Albumin Consumption by Type2.3.1 Global Albumin Consumption Market Share by Type (2014–2019)2.3.2 Global Albumin Revenue and Market Share by Type (2014–2019)2.3.3 Global Albumin Sale Price by Type (2014–2019)2.4 Albumin Segment by Application2.4.1 Therapeutics2.4.2 Vaccine Ingredient2.4.3 Culture Medium Ingredient2.4.4 Other2.5 Albumin Consumption by Application2.5.1 Global Albumin Consumption Market Share by Application (2014–2019)2.5.2 Global Albumin Value and Market Share by Application (2014–2019)2.5.3 Global Albumin Sale Price by Application (2014–2019)3 Global Albumin by Players3.1 Global Albumin Sales Market Share by Players3.1.1 Global Albumin Sales by Players (2017–2019)3.1.2 Global Albumin Sales Market Share by Players (2017–2019)CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
